跳至主要内容
临床试验/ACTRN12618001840279
ACTRN12618001840279尚未招募未知

Superiority of Oral or Intravenous administration of antibiotics in the treatment of moderate cellulitis, a randomised control trial.

Ashley Loughman0 个研究点目标入组 412 人开始时间: 2018年11月12日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
412

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • Presence of Cellulitis as defined by the presence of acute dermal/epidermal inflammation lasting <5 days and of probable infective aetiology. At least one marker of moderate severity, either a marker of systemic inflammatory response (documented temperature >37.8c, tachycardia >90bpm, systemic symptoms inc. malaise, flu like symptoms, nausea and vomiting or elevated inflammatory markers) or a risk factor eg. Diabetes, homelessness, etc.

排除标准

  • Patients will be excluded if they are unable to or decline consent; have mild cellulitis suitable for immediate discharge(limited area <10cm in longest axis, no risk factors, no systemic symptoms); cellulitis complicating trauma, intravenous drug use or recent (<30 days) surgical sites; periorbital cellulitis; immunosuppressed patients; morbidly obese patients; a diagnosis other than cellulitis or complicated cellulitis (severe sepsis, extensive bullous changes, abscess formation or suspected necrotising deep tissue involvement); vomiting precluding oral therapy or prior treatment with per protocol oral antimicrobials for >48 hours or parenteral antimicrobials

研究者

发起方
Ashley Loughman

相似试验

Is Oral or Intravenous administration of antibiotics... | 临床试验